Ajax Therapeutics has completed a $95 million financing, with plans to advance lead candidate AJ1‑11095 for myelofibrosis ...

Discovery of SLFN11 as the strongest biomarker for chemotherapy responsiveness suggests relevance for ribosomal stalling in ...

Sartorius plans to leverage NVIDIA solutions used in live-cell imaging platforms in drug discovery and in predictive ...

“A proinflammatory intestinal environment coincided with expansion, increased circulation, and migration of TNF-producing ...

The use of artificial intelligence (AI) has been increasing in scientific research and clinical applications. From ...

A new study shows some brain cells age faster than others in Alzheimer's cases, and there are sex-specific differences in the ...

Circe Biosciences entered into an exclusive worldwide licensing agreement arranged by Harvard's Office of Technology ...

A developer of pluripotent stem cell therapies has trademarked their approach to cost-effective therapy development.

Frédéric Revah, PhD, speaks with GEN's managing editor Corinna Singleman, PhD, about Généthon's past and future work in rare ...

Single Technologies has developed a confocal-based optical system to sequence a 3D matrix for hugely parallel reactions in ...

At ASGCT, Beverly Davidson highlights both recessive and dominant diseases in her talk, “Unlocking the power of AAV for brain ...

New technqiue could enable researchers to explore the inner workings of the brain in more detail than has previously been ...